Most states don’t cover GLP-1s for obesity treatment under Medicaid
States with Medicaid plans that cover one or more glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity treatment under fee-for-service
Note: As of January 2026.
Source: KFF.
Source: KFF.
PEW RESEARCH CENTER
Most states don’t cover GLP-1s for obesity treatment under Medicaid
States with Medicaid plans that cover one or more glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity treatment under fee-for-service
| Name | FIPS | Insurance coverage |
|---|---|---|
| Alabama | 01 | Not covered |
| Alaska | 02 | Not covered |
| Arizona | 04 | Not covered |
| Arkansas | 05 | Not covered |
| California | 06 | Not covered |
| Colorado | 08 | Not covered |
| Connecticut | 09 | Coverage for one or more weight loss drugs but not GLP-1s |
| Delaware | 10 | Coverage in place and covers GLP-1s for obesity treatment |
| District of Columbia | 11 | Not covered |
| Florida | 12 | Not covered |
| Georgia | 13 | Not covered |
| Hawaii | 15 | Not covered |
| Idaho | 16 | Not covered |
| Illinois | 17 | Not covered |
| Indiana | 18 | Not covered |
| Iowa | 19 | Not covered |
| Kansas | 20 | Coverage in place and covers GLP-1s for obesity treatment |
| Kentucky | 21 | Not covered |
| Louisiana | 22 | Coverage for one or more weight loss drugs but not GLP-1s |
| Maine | 23 | Not covered |
| Maryland | 24 | Not covered |
| Massachusetts | 25 | Coverage in place and covers GLP-1s for obesity treatment |
| Michigan | 26 | Coverage in place and covers GLP-1s for obesity treatment |
| Minnesota | 27 | Coverage in place and covers GLP-1s for obesity treatment |
| Mississippi | 28 | Coverage in place and covers GLP-1s for obesity treatment |
| Missouri | 29 | Coverage in place and covers GLP-1s for obesity treatment |
| Montana | 30 | Not covered |
| Nebraska | 31 | Not covered |
| Nevada | 32 | Not covered |
| New Hampshire | 33 | Coverage for one or more weight loss drugs but not GLP-1s |
| New Jersey | 34 | Not covered |
| New Mexico | 35 | Coverage for one or more weight loss drugs but not GLP-1s |
| New York | 36 | Not covered |
| North Carolina | 37 | Coverage in place and covers GLP-1s for obesity treatment |
| North Dakota | 38 | Coverage for one or more weight loss drugs but not GLP-1s |
| Ohio | 39 | Not covered |
| Oklahoma | 40 | Not covered |
| Oregon | 41 | Not covered |
| Pennsylvania | 42 | Coverage for one or more weight loss drugs but not GLP-1s |
| Rhode Island | 44 | Coverage in place and covers GLP-1s for obesity treatment |
| South Carolina | 45 | Not covered |
| South Dakota | 46 | Not covered |
| Tennessee | 47 | Coverage in place and covers GLP-1s for obesity treatment |
| Texas | 48 | Coverage for one or more weight loss drugs but not GLP-1s |
| Utah | 49 | Coverage in place and covers GLP-1s for obesity treatment |
| Vermont | 50 | Not covered |
| Virginia | 51 | Coverage in place and covers GLP-1s for obesity treatment |
| Washington | 53 | Not covered |
| West Virginia | 54 | Not covered |
| Wisconsin | 55 | Coverage in place and covers GLP-1s for obesity treatment |
| Wyoming | 56 | Not covered |
Note: As of January 2026.
Source: KFF.
Source: KFF.
PEW RESEARCH CENTER
